BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Should You Try MOTS c and BPC 157 Longevity Peptides? Separating Truth from Hype with Human Data Studies The Science Behind Our BPC 157 Peptide The FDA Is Unbanning Peptides! (BPC 157, TB 500) #peptides #breakingnews